#008 National consultant to provide technical assistance in the areas of HIV, viral hepatitis and STIs

Background

Viet Nam is home of nearly 8 million people living with HBV and HCV and 250,000 people living with HIV. HCV and HBV are leading causes of cirrhosis, liver cancer and liver-related deaths in Viet Nam. Viet Nam is also one of the high burden of tuberculosis (TB) countries in the world with 172,000 new cases in 2022 including 4,300 people had HIV positive. Consequently, TB and viral hepatitis are major causes of death among people living with HIV. Increasing trend of sexually transmitted infections (STIs) especially among men who have sex with men (MSM) and emerging anti-microbial resistance of gonorrhoea in Viet Nam has been reported. To address these critical public health issues, the government of Viet Nam aim to ending AIDS Epidemic by 2030 and Tuberculosis by 2035 and moving toward elimination of viral hepatitis as public health threat also by 2030. To achieve these elimination goals, it is critical to address the current barriers related to access to testing, diagnosis and treatment of these diseases including monitoring drug resistance.

The Ministry of Health has requested the WHO Representative Office in Viet Nam to continue providing technical assistance to the government of Viet Nam to achieve the national elimination targets including enhance primary health care facility to enable to provide essential services through decentralization and integration of HIV and viral hepatitis services at district health facilities, empower community to provide testing services to key populations who are at substantial risk of HIV, hepatitis C and STIs, and monitoring drug resistance of HIV and STIs.

The above activities will contribute the achievement of the WHO strategic priorities on improvement of grass roots health care, as a key part of quality, people-centred integrated health service delivery, focusing on essential health services & functions to meet health needs of the population, reaching the unreached & strengthening the impact of disease-specific programs.

Planned timelines (subject to confirmation)

Start date: 5/2024

End date: 3/2025

Work to be performed

The consultant is required to work full time at WHO office during consultancy period to formulating and managing the implementation of the WHO supported - demonstration pilot projects including coordination of relevant stakeholders, monitoring, supervising of the technical team; conducting evaluation and development of report for disseminations.

Please refer to the Call for Expressions of Interest and Proposal for more details. Those who are interested can submit the following documents: